Towards topical microRNA-directed therapy for epidermal disorders

Area of Science:

• Dermatology
• Molecular Biology
• Nanotechnology

Background:

• There is a need for novel topical dermatological agents with improved long-term efficacy and reduced side effects.
• MicroRNA (miRNA) modulation is an emerging therapeutic strategy due to its broad impact on cellular processes.
• Dysregulated miRNA expression is implicated in various skin conditions, including psoriasis and cutaneous squamous cell carcinoma.

Purpose of the Study:

• To review the role of miRNAs in epidermal development and disease.
• To explore the potential of miRNA-based therapies for dermatological applications.
• To discuss advanced delivery systems for oligonucleotide therapeutics.

Main Methods:

• Review of current literature on miRNA function in skin biology and disease.
• Analysis of various nanocarrier systems for oligonucleotide delivery to the skin.
• Exploration of RNA-based therapeutic strategies.

Main Results:

• miRNAs play critical roles in epidermal development, psoriasis, and skin cancer.
• Various advanced delivery vehicles, including cell penetrating peptides and nanodispersions, show promise for miRNA oligonucleotide delivery.
• Formulation of miRNA-directed oligonucleotides with skin-penetrating agents is key for RNA-based cutaneous therapeutics.

Conclusions:

• miRNA modulation represents a promising avenue for developing innovative topical dermatological treatments.
• Effective delivery of miRNA oligonucleotides via advanced nanocarriers is crucial for therapeutic success.
• RNA-based therapeutics hold potential as primary or adjuvant treatments for epidermal disorders.